LNTH vs. APLS
Compare and contrast key facts about Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LNTH or APLS.
Correlation
The correlation between LNTH and APLS is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LNTH vs. APLS - Performance Comparison
Loading data...
Key characteristics
LNTH:
-0.10
APLS:
-1.05
LNTH:
0.28
APLS:
-1.75
LNTH:
1.04
APLS:
0.79
LNTH:
-0.21
APLS:
-0.72
LNTH:
-0.40
APLS:
-1.74
LNTH:
21.03%
APLS:
33.98%
LNTH:
65.39%
APLS:
54.30%
LNTH:
-78.62%
APLS:
-82.47%
LNTH:
-40.25%
APLS:
-81.31%
Fundamentals
LNTH:
$5.17B
APLS:
$2.19B
LNTH:
$3.51
APLS:
-$1.80
LNTH:
3.37
APLS:
2.83
LNTH:
4.44
APLS:
13.61
LNTH:
$1.54B
APLS:
$775.84M
LNTH:
$984.15M
APLS:
$643.52M
LNTH:
$438.66M
APLS:
-$176.07M
Returns By Period
In the year-to-date period, LNTH achieves a -17.44% return, which is significantly higher than APLS's -45.35% return.
LNTH
-17.44%
-27.02%
-18.40%
-6.51%
5.02%
42.21%
N/A
APLS
-45.35%
-0.29%
-43.32%
-56.05%
-25.72%
-12.95%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LNTH vs. APLS — Risk-Adjusted Performance Rank
LNTH
APLS
LNTH vs. APLS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LNTH vs. APLS - Dividend Comparison
Neither LNTH nor APLS has paid dividends to shareholders.
Drawdowns
LNTH vs. APLS - Drawdown Comparison
The maximum LNTH drawdown since its inception was -78.62%, roughly equal to the maximum APLS drawdown of -82.47%. Use the drawdown chart below to compare losses from any high point for LNTH and APLS. For additional features, visit the drawdowns tool.
Loading data...
Volatility
LNTH vs. APLS - Volatility Comparison
Lantheus Holdings, Inc. (LNTH) has a higher volatility of 27.26% compared to Apellis Pharmaceuticals, Inc. (APLS) at 16.42%. This indicates that LNTH's price experiences larger fluctuations and is considered to be riskier than APLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LNTH vs. APLS - Financials Comparison
This section allows you to compare key financial metrics between Lantheus Holdings, Inc. and Apellis Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LNTH vs. APLS - Profitability Comparison
LNTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported a gross profit of 237.70M and revenue of 372.76M. Therefore, the gross margin over that period was 63.8%.
APLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported a gross profit of 132.44M and revenue of 166.80M. Therefore, the gross margin over that period was 79.4%.
LNTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported an operating income of 102.07M and revenue of 372.76M, resulting in an operating margin of 27.4%.
APLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported an operating income of -83.33M and revenue of 166.80M, resulting in an operating margin of -50.0%.
LNTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lantheus Holdings, Inc. reported a net income of 72.95M and revenue of 372.76M, resulting in a net margin of 19.6%.
APLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported a net income of -92.23M and revenue of 166.80M, resulting in a net margin of -55.3%.